[1]
X. Sabirova, “CRISPR-Cas13 RNA Editing for Tauopathy Treatment: Single-AAV Delivery from VIVARY Lab”, J Clin Biomed Res, vol. 1, no. 1, pp. 289–293, Jan. 2026.